Resultados de procura - Cynthia Behling
- Mostrando 1 - 20 Resultados de 48
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease por Jeffrey B. Schwimmer, Anne Zepeda, Kimberly P. Newton, Stavra A. Xanthakos, Cynthia Behling, Erin Hallinan, Michele Donithan, James Tonascia
Publicado 2014Artigo -
6
Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer por John Welsh, Patrick P. Zarrinkar, Lisa M. Sapinoso, S Kern, Cynthia Behling, Bradley J. Monk, David J. Lockhart, Robert A. Burger, Garret M. Hampton
Publicado 2001Artigo -
7
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C por Keyur Patel, Adrianne LaJoie, Shanon Heaton, Stephen Pianko, Cynthia Behling, David Bylund, PAULJ POCKROS, Lawrence M. Blatt, Andrew Conrad, John G. McHutchison
Publicado 2003Artigo -
8
Association Between Metabolic Syndrome and Liver Histology Among Children With Nonalcoholic Fatty Liver Disease por Heather Patton, Katherine P. Yates, Aynur Ünalp–Arida, Cynthia Behling, Terry T.‐K. Huang, Philip Rosenthal, Arun J. Sanyal, Jeffrey B. Schwimmer, Joel E. Lavine
Publicado 2010Artigo -
9
Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion‐weighted MRI measurements in adults por P. Murphy, Jonathan Hooker, Brandon Ang, Tanya Wolfson, Anthony Gamst, Mark Bydder, Michael S. Middleton, Michael R. Peterson, Cynthia Behling, Rohit Loomba, Claude B. Sirlin
Publicado 2014Artigo -
10
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease por Nobuharu Tamaki, Nagambika Munaganuru, Jinho Jung, Aed Qas Yonan, Rohan Loomba, Richele Bettencourt, Veeral Ajmera, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Rohit Loomba
Publicado 2021Artigo -
11
Magnetic resonance elastography plus Fibrosis‐4 versus FibroScan–aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH‐related fibrosis por Nobuharu Tamaki, Kento Imajo, Suzanne R. Sharpton, Jinho Jung, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajima, Rohit Loomba
Publicado 2021Artigo -
12
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes por Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, Heather Hofflich, Karen Cadman, Scarlett Lopez, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Cynthia Behling, Claude B. Sirlin, Rohit Loomba
Publicado 2022Artigo -
13
Artificial intelligence scoring of liver biopsies in a phase ii trial of semaglutide in non-alcoholic steatohepatitis por Vlad Ratziu, Sven Francque, Cynthia Behling, Vanja Cejvanovic, Helena Cortez‐Pinto, Janani Iyer, Niels Krarup, Quang Le, Anne‐Sophie Sejling, Dina Tiniakos, Stephen A. Harrison
Publicado 2023Artigo -
14
Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease por Jeffrey B. Schwimmer, Michael S. Middleton, Cynthia Behling, Kimberly P. Newton, Hannah I. Awai, Melissa Paiz, Jessica Lam, Jonathan Hooker, Gavin Hamilton, John Fontanesi, Claude B. Sirlin
Publicado 2014Artigo -
15
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer por John M. Carethers, Edward J. Smith, Cynthia Behling, Lanchinh Nguyen, Akihiro Tajima, Ryan T. Doctolero, Betty L. Cabrera, Ajay Goel, Christian Arnold, Katsumi Miyai, C. Richard Boland
Publicado 2004Artigo -
16
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study por Rohit Loomba, Tanya Wolfson, Brandon Ang, Jonathan Hooker, Cynthia Behling, Michael R. Peterson, Mark A. Valasek, Grace Lin, David A. Brenner, Anthony Gamst, Richard L. Ehman, Claude B. Sirlin
Publicado 2014Artigo -
17
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial por Stephen A. Harrison, Peter Ruane, B. Freilich, Guy Neff, Rashmee Patil, Cynthia Behling, Chen Hu, Erica Fong, Brittany de Temple, Erik J. Tillman, Tim Rolph, Andrew Cheng, Kitty Yale
Publicado 2021Artigo -
18
Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease por Kimberly P. Newton, Jiayi Hou, Nancy A. Crimmins, Joel E. Lavine, Sarah E. Barlow, Stavra A. Xanthakos, Jonathan A. Africa, Cynthia Behling, Michele Donithan, Jeanne M. Clark, Jeffrey B. Schwimmer
Publicado 2016Artigo -
19
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease por Daniel Q. Huang, Suzanne R. Sharpton, Maral Amangurbanova, Nobuharu Tamaki, Claude B. Sirlin, Rohit Loomba, Ricki Bettencourt, Egbert Madamba, Jinho Jung, Harris Siddiqi, Lisa Richards, Mark A. Valasek, Cynthia Behling
Publicado 2022Carta -
20
Alanine Aminotransferase and Gamma‐Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis por Kimberly P. Newton, Joel E. Lavine, Laura Wilson, Cynthia Behling, Miriam B. Vos, Jean P. Molleston, Philip Rosenthal, Tamir Miloh, Mark Fishbein, Ajay K. Jain, Karen F. Murray, Jeffrey B. Schwimmer
Publicado 2020Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Disease
Fatty liver
Gastroenterology
Fibrosis
Nonalcoholic fatty liver disease
Pathology
Biopsy
Liver biopsy
Steatohepatitis
Biology
Cirrhosis
Radiology
Steatosis
Magnetic resonance imaging
Liver disease
Confidence interval
Paleontology
Prospective cohort study
Stage (stratigraphy)
Alternative medicine
Body mass index
Liver fibrosis
Nonalcoholic steatohepatitis
Odds ratio
Ultrasound
Biochemistry
Diabetes mellitus
Elastography